Similar articles

• Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban).

  Assali AR, Salloum J, Sdringola S, Moustapha A, Ghani M, Hale S, Schroth G, Fujise K, Anderson HV, Smalling RW, Rosales OR. Assali AR, et al. Am J Cardiol. 2001 Oct 15;88(8):884-6, A6. doi: 10.1016/s0002-9149(01)01897-5. Am J Cardiol. 2001. PMID: 11676953 No abstract available.
• Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

  Topol EJ, Moliterno DJ, Herrmann HC, Powers ER, Grines CL, Cohen DJ, Cohen EA, Bertrand M, Neumann FJ, Stone GW, DiBattiste PM, Demopoulos L; TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial. Topol EJ, et al. N Engl J Med. 2001 Jun 21;344(25):1888-94. doi: 10.1056/NEJM200106213442502. N Engl J Med. 2001. PMID: 11419425 Clinical Trial.
• A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.

  Moliterno DJ; TENACITY Steering Committee and Investigators. Moliterno DJ, et al. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9. doi: 10.1002/ccd.22876. Epub 2011 Jan 11. Catheter Cardiovasc Interv. 2011. PMID: 21598351 Clinical Trial.
• Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.

  Tcheng JE. Tcheng JE. Am J Cardiol. 1996 Aug 14;78(3A):35-40. doi: 10.1016/s0002-9149(96)00490-0. Am J Cardiol. 1996. PMID: 8751845 Review.
• GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.

  Chew DP, Moliterno DJ. Chew DP, et al. Cleve Clin J Med. 2001 Dec;68(12):1017-23. doi: 10.3949/ccjm.68.12.1017. Cleve Clin J Med. 2001. PMID: 11765119 Review.